
|Articles|May 16, 2020
ASCRS 2020: Updates, improved injection technique from Eyepoint Pharmaceuticals
Author(s)Alex Delaney-Gesing
Advertisement
Ophthalmology Times' Sheryl Stevenson speaks with Eyepoint Pharmaceuticals' President/CEO Nancy Lurker and Chief Medical Officer Dario Paggiarino, MD, on the company's latest developments and research ahead of the ASCRS 2020 virtual meeting.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA extends Aldeyra's reproxalap PDUFA after requesting additional clinical study report
2
Spotlight on women's health: Understanding thyroid eye disease
3
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy
4
Strategic approaches optimize teaching and learning in the clinic
5









































